Neoplasms, Connective and Soft Tissue  >>  everolimus  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
everolimus / Generic mfg.
EXIST-2, NCT00790400 / 2008-002113-48: Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)

Checkmark EXIST-2: Angiomyolipoma
Jan 2013 - Jan 2013: EXIST-2: Angiomyolipoma
Checkmark P3 data
Jan 2013 - Jan 2013: P3 data
Checkmark P3 data - ASCO
More
Completed
3
118
Japan, US, Canada, Europe, RoW
Everolimus (RAD001), RAD001, Everolimus Placebo
Novartis Pharmaceuticals
Tuberous Sclerosis Complex (TSC), Lymphangioleiomyomatosis (LAM)
06/11
11/15

Download Options